Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qishen Yiqi dropping pills after PCI for coronary heart disease
ChiCTR2000040838Phase 4Recruiting
- Sponsor
- China-Japan Friendship Hospital
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in coronary arteriosclerosis comparing Qishen Yiqi dropping pill group with Blank placebo control group (2 arms). Primary endpoint: Peak oxygen consumption change rate. Started Dec 2020; status: recruiting.
02
Drugs
Qishenyiqi Dripping Pills
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on ChiCTR2000040838.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000040838.